NFKB1 and breast neoplasm: In this study, we hypothesize that SEC-PCP-SILAC is able to map the pro-tumorigenic NF-κB protein–protein interactions and their response to NF-κB modulation in MCF-7 cell line derived from luminal A breast tumor.